Pediatric Cancer Archives - Cancer Therapy Advisor

Tafinlar Plus Mekinist Approved for Pediatric BRAF V600E Low-Grade Glioma

By

Diana Ernst, RPh

March 20, 2023

The FDA approved the combination to treat pediatric patients 1 year of age and older who have low-grade glioma with a BRAF V600E mutation and require systemic therapy.

General Oncology

Cost of Cancer for AYAs Exceeds $250,000 Over a Lifetime

By

Andrea S. Blevins Primeau, PhD, MBA

March 9, 2023

In the US, AYAs with cancer face high economic and human costs throughout their lifetime.

Hematologic Cancers

Texas-Mexico Border Residence Linked to Worse Survival in Children With ALL

By

Leah Lawrence

February 28, 2023

Living along the Texas-Mexico border is associated with worse survival in children diagnosed with acute lymphoblastic leukemia.

Tandem Meetings 2023

Responses Fleeting With CAR-T Reinfusion in Children, AYAs With B-ALL

By

Laura M. Healy

February 27, 2023

Reinfusion with the CAR T-cell therapy tisagenlecleucel does not produce durable remissions in children and AYAs with B-ALL, a study suggests.

Hematologic Cancers

Maternal Infection Linked to Increased Risk of Childhood Leukemia

February 24, 2023

Maternal infections, especially genital and urinary tract infections, during pregnancy are associated with an increased risk of childhood leukemia in offspring, a study suggests.

Head and Neck Cancer

Social Vulnerability Tied to Worse Pediatric Head and Neck Cancer Outcomes

February 24, 2023

Increasing social vulnerability is associated with significant decreases in surveillance and survival time among pediatric patients with head and neck cancers.